Stand Up To Cancer has awarded a total of $1 million to four teams of cancer researchers to advance innovation in collaboration. Each team, consisting of researchers from different supported “Dream Teams” or research programs who have not previously worked together, will receive a grant of $250,000 over two years to support new research projects.
One of the award winners, UCLA’s Dr. Siwen Hu-Lieskovan will be teaming up with René Bernards of The Netherlands Cancer Institute to study “Interrogation of Resistance Mechanisms to Checkpoint Inhibitors Using Functional Genomics. “
“Stand Up To Cancer works to break down the barriers to innovation by encouraging collaboration among the best researchers in order to advance science and benefit cancer patients,” said Phillip A. Sharp, chair of its scientific advisory committee and a Nobel Prize winner for his research in genetics. “These teams and their research will help bring us closer to the day we defeat cancer.”
Dr. Hu-Lieskovan is a physician-scientist conducting clinical and laboratory research focused in immunotherapy for advanced solid malignancies. She received her M.D. from China Medical University and her Ph.D. from the University of Southern California. Dr. Hu-Lieskovan has been a part of UCLA since 2011, first, as a fellow in the oncology department, and, then as a cancer researcher.
